Literature DB >> 8977710

Cathepsin B and D expression in squamous cell carcinoma.

A Kawada1, K Hara, E Kominami, T Kobayashi, M Hiruma, A Ishibashi.   

Abstract

To elucidate involvement of proteinases in malignancy of keratinocytes, expression of cathepsin B, a cysteine proteinase, and cathepsin D, an aspartic proteinase, was ascertained in formalin-fixed paraffin-embedded specimens of normal skin, squamous cell carcinoma (SCC). Bowen's disease, seborrhoeic keratosis and basal cell carcinoma (BCC). Presence of procathepsin B and an intermediate form of cathepsin D was confirmed by Western blotting and enzyme activity analysis. Cathepsin B stained more intensely in SCC tumour cells than in normal epidermis; staining patterns were diffuse, granular or both. Diffuse and granular patterns (procathepsin B and mature enzyme, respectively) appeared in inner and outer parts of tumour islands, respectively. Five of 20 cases of Bowen's disease showed diffuse enhanced cathepsin B expression; 20 cases of seborrhoeic keratosis or BCC did not. Cathepsin D stained intensely in tumour cells of half the SCC cases. The staining manner and distribution of cathepsins B and D was similar in the cytoplasm of cancer cells. No enhanced staining of cathepsin D was seen in any cases of Bowen's disease, seborrhoeic keratosis, or BCC. Coexistence and localization of active mature forms of cathepsins B and D suggests that cooperation between the two enzymes may play an important part in invasion of SCC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977710     DOI: 10.1046/j.1365-2133.1996.d01-1093.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision.

Authors:  Ethan Walker; Yiqiao Liu; InYoung Kim; David L Wilson; James P Basilion; Daniel L Popkin; Mark Biro; Sukanya Raj Iyer; Harib Ezaldein; Jeffrey Scott; Miesha Merati; Rachel Mistur; Bo Zhou; Brian Straight; Joshua J Yim; Matthew Bogyo; Margaret Mann
Journal:  Cancer Res       Date:  2020-03-04       Impact factor: 12.701

2.  Rapid visualization of nonmelanoma skin cancer.

Authors:  Ethan Walker; Margaret Mann; Kord Honda; Allison Vidimos; Mark D Schluchter; Brian Straight; Matthew Bogyo; Daniel Popkin; James P Basilion
Journal:  J Am Acad Dermatol       Date:  2016-11-19       Impact factor: 11.527

Review 3.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.

Authors:  Jeffrey M Schafer; Diane E Peters; Thomas Morley; Shihui Liu; Alfredo A Molinolo; Stephen H Leppla; Thomas H Bugge
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

5.  Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes.

Authors:  Ji Young Yhee; Sun Ah Kim; Heebeom Koo; Sohee Son; Ju Hee Ryu; In-Chan Youn; Kuiwon Choi; Ick Chan Kwon; Kwangmeyung Kim
Journal:  Theranostics       Date:  2012-02-10       Impact factor: 11.556

6.  A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment.

Authors:  Raghu S Pandurangi; Marco Tomasetti; Sekar T Verapazham; Ramasamy Paulmurugan; Cynthia Ma; Sandeep Rajput; Manjushree Anjanappa; Harikrishna Nakshatri
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

7.  Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.

Authors:  Felix Humphries; Bridget Chang-McDonald; Josie Patel; Nicholas Bockett; Erin Paterson; Paul F Davis; Swee T Tan
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.